Table of Contents Author Guidelines Submit a Manuscript
Journal of Diabetes Research
Volume 2017, Article ID 1426705, 5 pages
https://doi.org/10.1155/2017/1426705
Research Article

Natriuretic Peptide System Activation in Acute Heart Failure Patients with Diabetes

1Serviço de Endocrinologia do Centro Hospitalar de Trás-os-Montes e Alto Douro, Vila Real, Portugal
2Serviço de Medicina Interna do Centro Hospitalar de São João, Porto, Portugal
3Faculdade de Medicina da Universidade do Porto, Porto, Portugal
4Hospital CUF Porto, Porto, Portugal

Correspondence should be addressed to Filipe M. Cunha; moc.liamg@ahnucrmepilif

Received 21 May 2017; Revised 8 July 2017; Accepted 10 July 2017; Published 2 August 2017

Academic Editor: Janet H. Southerland

Copyright © 2017 Filipe M. Cunha et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. W. B. Kannel, M. Hjortland, and W. P. Castelli, “Role of diabetes in congestive heart failure: the Framingham study,” The American Journal of Cardiology, vol. 34, no. 1, pp. 29–34, 1974. View at Google Scholar
  2. A. A. Leung, D. T. Eurich, D. A. Lamb et al., “Risk of heart failure in patients with recent-onset type 2 diabetes: population-based cohort study,” Journal of Cardiac Failure, vol. 15, no. 2, pp. 152–157, 2009. View at Publisher · View at Google Scholar · View at Scopus
  3. S. Sarma, R. J. Mentz, M. J. Kwasny et al., “Association between diabetes mellitus and post-discharge outcomes in patients hospitalized with heart failure: findings from the EVEREST trial,” European Journal of Heart Failure, vol. 15, no. 2, pp. 194–202, 2013. View at Publisher · View at Google Scholar · View at Scopus
  4. M. R. MacDonald, M. C. Petrie, F. Varyani et al., “Impact of diabetes on outcomes in patients with low and preserved ejection fraction heart failure: an analysis of the Candesartan in heart failure: assessment of reduction in mortality and morbidity (CHARM) programme,” European Heart Journal, vol. 29, no. 11, pp. 1377–1385, 2008. View at Publisher · View at Google Scholar · View at Scopus
  5. B. H. Greenberg, W. T. Abraham, N. M. Albert et al., “Influence of diabetes on characteristics and outcomes in patients hospitalized with heart failure: a report from the Organized Program to Initiate Lifesaving Treatment in Hospitalized Patients with Heart Failure (OPTIMIZE-HF),” American Heart Journal, vol. 154, no. 2, pp. 277.e1–277.e8, 2007. View at Publisher · View at Google Scholar · View at Scopus
  6. P. D. Groote, N. Lamblin, F. Mouquet et al., “Impact of diabetes mellitus on long-term survival in patients with congestive heart failure,” European Heart Journal, vol. 25, no. 8, pp. 656–662, 2004. View at Publisher · View at Google Scholar · View at Scopus
  7. M. Domanski, H. Krause-Steinrauf, P. Deedwania et al., “The effect of diabetes on outcomes of patients with advanced heart failure in the BEST trial,” Journal of the American College of Cardiology, vol. 42, no. 5, pp. 914–922, 2003. View at Google Scholar
  8. L. B. Daniels and A. S. Maisel, “Natriuretic peptides,” Journal of the American College of Cardiology, vol. 50, no. 25, pp. 2357–2368, 2007. View at Google Scholar
  9. M. Volpe, M. Carnovali, and V. Mastromarino, “The natriuretic peptides system in the pathophysiology of heart failure: from molecular basis to treatment,” Clinical Science (London, England), vol. 130, no. 2, pp. 57–77, 2016. View at Publisher · View at Google Scholar · View at Scopus
  10. M. Weber and C. Hamm, “Role of B-type natriuretic peptide (BNP) and NT-proBNP in clinical routine,” Heart, vol. 92, no. 6, pp. 843–849, 2006. View at Publisher · View at Google Scholar · View at Scopus
  11. A. Dei Cas, S. S. Khan, J. Butler et al., “Impact of diabetes on epidemiology, treatment, and outcomes of patients with heart failure,” JACC: Heart Failure, vol. 3, no. 2, pp. 136–145, 2015. View at Publisher · View at Google Scholar · View at Scopus
  12. C. Bauters, N. Lamblin, E. P. Mc Fadden, E. V. Belle, A. Millaire, and P. d. Groote, “Influence of diabetes mellitus on heart failure risk and outcome,” Cardiovascular Diabetology, vol. 2, p. 1, 2003. View at Google Scholar
  13. J. Kasznicki and J. Drzewoski, “Heart failure in the diabetic population - pathophysiology, diagnosis and management,” Archives of Medical Science, vol. 10, no. 3, pp. 546–556, 2014. View at Publisher · View at Google Scholar · View at Scopus
  14. F. Paneni, J. A. Beckman, M. A. Creager, and F. Cosentino, “Diabetes and vascular disease: pathophysiology, clinical consequences, and medical therapy: part I,” European Heart Journal, vol. 34, no. 31, pp. 2436–2443, 2013. View at Publisher · View at Google Scholar · View at Scopus
  15. M. Magnusson, O. Melander, B. Israelsson, A. Grubb, L. Groop, and S. Jovinge, “Elevated plasma levels of Nt-proBNP in patients with type 2 diabetes without overt cardiovascular disease,” Diabetes Care, vol. 27, no. 8, pp. 1929–1935, 2004. View at Google Scholar
  16. J. P. Albertini, R. Cohen, P. Valensi, R. N. Sachs, and J. C. Charniot, “B-type natriuretic peptide, a marker of asymptomatic left ventricular dysfunction in type 2 diabetic patients,” Diabetes & Metabolism, vol. 34, no. 4, Part 1, pp. 355–362, 2008. View at Publisher · View at Google Scholar · View at Scopus
  17. T. Wei, C. Zeng, L. Chen et al., “Systolic and diastolic heart failure are associated with different plasma levels of B-type natriuretic peptide,” International Journal of Clinical Practice, vol. 59, no. 8, pp. 891–894, 2005. View at Publisher · View at Google Scholar · View at Scopus
  18. M. M. Redfield, R. J. Rodeheffer, S. J. Jacobsen, D. W. Mahoney, K. R. Bailey, and J. C. Burnett Jr., “Plasma brain natriuretic peptide concentration: impact of age and gender,” Journal of the American College of Cardiology, vol. 40, no. 5, pp. 976–982, 2002. View at Google Scholar
  19. T. Tsutamoto, A. Wada, H. Sakai et al., “Relationship between renal function and plasma brain natriuretic peptide in patients with heart failure,” Journal of the American College of Cardiology, vol. 47, no. 3, pp. 582–586, 2006. View at Publisher · View at Google Scholar · View at Scopus
  20. A. Clerico, A. Giannoni, S. Vittorini, and M. Emdin, “The paradox of low BNP levels in obesity,” Heart Failure Reviews, vol. 17, no. 1, pp. 81–96, 2012. View at Publisher · View at Google Scholar · View at Scopus
  21. I. C. van der Horst, R. A. de Boer, H. L. Hillege, F. Boomsma, A. A. Voors, and D. J. van Veldhuisen, “Neurohormonal profile of patients with heart failure and diabetes,” Netherland Heart Journal, vol. 18, no. 4, pp. 190–196, 2010. View at Google Scholar
  22. K. Dickstein, A. Cohen-Solal, G. Filippatos et al., “ESC guidelines for the diagnosis and treatment of acute and chronic heart failure 2008: the task force for the diagnosis and treatment of acute and chronic heart failure 2008 of the European Society of Cardiology. Developed in collaboration with the Heart Failure Association of the ESC (HFA) and endorsed by the European Society of Intensive Care Medicine (ESICM),” European Heart Journal, vol. 29, no. 19, pp. 2388–2442, 2008. View at Publisher · View at Google Scholar · View at Scopus
  23. R. Sarzani, P. Dessi-Fulgheri, V. M. Paci, E. Espinosa, and A. Rappelli, “Expression of natriuretic peptide receptors in human adipose and other tissues,” Journal of Endocrinological Investigation, vol. 19, no. 9, pp. 581–585, 1996. View at Google Scholar
  24. H. K. Gaggin and J. L. Januzzi Jr., “Biomarkers and diagnostics in heart failure,” Biochimica et Biophysica Acta, vol. 1832, no. 12, pp. 2442–2450, 2013. View at Publisher · View at Google Scholar · View at Scopus
  25. G. Gruden, A. Landi, and G. Bruno, “Natriuretic peptides, heart, and adipose tissue: new findings and future developments for diabetes research,” Diabetes Care, vol. 37, no. 11, pp. 2899–2908, 2014. View at Publisher · View at Google Scholar · View at Scopus